Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections.

Vanić Ž, Rukavina Z, Manner S, Fallarero A, Uzelac L, Kralj M, Amidžić Klarić D, Bogdanov A, Raffai T, Virok DP, Filipović-Grčić J, Škalko-Basnet N.

Int J Nanomedicine. 2019 Jul 30;14:5957-5976. doi: 10.2147/IJN.S211691. eCollection 2019.

2.

Antimicrobial Resistance Screening in Chlamydia trachomatis by Optimized McCoy Cell Culture System and Direct qPCR-Based Monitoring of Chlamydial Growth.

Meštrović T, Virok DP, Ljubin-Sternak S, Raffai T, Burián K, Vraneš J.

Methods Mol Biol. 2019;2042:33-43. doi: 10.1007/978-1-4939-9694-0_5.

PMID:
31385269
3.

Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues.

Virok DP, Raffai T, Kókai D, Paróczai D, Bogdanov A, Veres G, Vécsei L, Poliska S, Tiszlavicz L, Somogyvári F, Endrész V, Burián K.

Front Cell Infect Microbiol. 2019 Jun 12;9:192. doi: 10.3389/fcimb.2019.00192. eCollection 2019.

4.

Vaginal Gel Component Hydroxyethyl Cellulose Significantly Enhances the Infectivity of Chlamydia trachomatis Serovars D and E.

Raffai T, Burián K, Janovák L, Bogdanov A, Hegemann JH, Endrész V, Virok DP.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e02034-18. doi: 10.1128/AAC.02034-18. Print 2019 Jan.

5.

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Lantos I, Endrész V, Virok DP, Szabó A, Lu X, Mosolygó T, Burián K.

Biomed Res Int. 2018 Mar 25;2018:8325915. doi: 10.1155/2018/8325915. eCollection 2018.

6.

Growth characteristics of Chlamydia trachomatis in human intestinal epithelial Caco-2 cells.

Lantos I, Virok DP, Mosolygó T, Rázga Z, Burián K, Endrész V.

Pathog Dis. 2018 Apr 1;76(3). doi: 10.1093/femspd/fty024.

PMID:
29635314
7.

N-acetyl-cysteine increases the replication of Chlamydia pneumoniae and prolongs the clearance of the pathogen from mice.

Kókai D, Mosolygó T, Virók DP, Endrész V, Burián K.

J Med Microbiol. 2018 Mar 9. doi: 10.1099/jmm.0.000716. [Epub ahead of print]

PMID:
29521616
8.

Nonactivated titanium-dioxide nanoparticles promote the growth of Chlamydia trachomatis and decrease the antimicrobial activity of silver nanoparticles.

Bogdanov A, Janovák L, Lantos I, Endrész V, Sebők D, Szabó T, Dékány I, Deák J, Rázga Z, Burián K, Virok DP.

J Appl Microbiol. 2017 Nov;123(5):1335-1345. doi: 10.1111/jam.13560. Epub 2017 Sep 15.

PMID:
28799270
9.

Assembly and use of high-density recombinant peptide chips for large-scale ligand screening is a practical alternative to synthetic peptide libraries.

Hundsberger H, Önder K, Schuller-Götzburg P, Virok DP, Herzog J, Rid R.

BMC Genomics. 2017 Jun 8;18(1):450. doi: 10.1186/s12864-017-3814-3.

10.

A direct quantitative PCR-based measurement of herpes simplex virus susceptibility to antiviral drugs and neutralizing antibodies.

Virók DP, Eszik I, Mosolygó T, Önder K, Endrész V, Burián K.

J Virol Methods. 2017 Apr;242:46-52. doi: 10.1016/j.jviromet.2017.01.007. Epub 2017 Jan 16.

PMID:
28093274
11.

Impact of antiseptics on Chlamydia trachomatis growth.

Párducz L, Eszik I, Wagner G, Burián K, Endrész V, Virok DP.

Lett Appl Microbiol. 2016 Oct;63(4):260-7. doi: 10.1111/lam.12625.

12.

High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells.

Eszik I, Lantos I, Önder K, Somogyvári F, Burián K, Endrész V, Virok DP.

J Microbiol Methods. 2016 Jan;120:15-22. doi: 10.1016/j.mimet.2015.11.010. Epub 2015 Nov 11.

PMID:
26578244
13.

Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice.

Mosolygó T, Szabó AM, Balogh EP, Faludi I, Virók DP, Endrész V, Samu A, Krenács T, Burián K.

Vaccine. 2014 Sep 8;32(40):5228-33. doi: 10.1016/j.vaccine.2014.07.039. Epub 2014 Jul 29.

PMID:
25077421
14.

Anti-chlamydial effect of plant peptides.

Balogh EP, Mosolygó T, Tiricz H, Szabó AM, Karai A, Kerekes F, Virók DP, Kondorosi E, Burián K.

Acta Microbiol Immunol Hung. 2014 Jun;61(2):229-39. doi: 10.1556/AMicr.61.2014.2.12.

PMID:
24939689
15.

Expression of Chlamydia muridarum plasmid genes and immunogenicity of pGP3 and pGP4 in different mouse strains.

Mosolygó T, Faludi I, Balogh EP, Szabó ÁM, Karai A, Kerekes F, Virók DP, Endrész V, Burián K.

Int J Med Microbiol. 2014 May;304(3-4):476-83. doi: 10.1016/j.ijmm.2014.02.005. Epub 2014 Feb 19.

PMID:
24631212
16.

Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array.

May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, Brüning T, Pesch B, Stephan C, Woitalla D, Penke B, Janáky T, Virók D, Siklós L, Engelhardt JI, Meyer HE.

PLoS One. 2014 Feb 26;9(2):e89596. doi: 10.1371/journal.pone.0089596. eCollection 2014.

17.

Chryseobacterium gleum - a novel bacterium species detected in neonatal respiratory tract infections.

Virok DP, Ábrók M, Szél B, Tajti Z, Mader K, Urbán E, Tálosi G.

J Matern Fetal Neonatal Med. 2014 Dec;27(18):1926-9. doi: 10.3109/14767058.2014.880881. Epub 2014 Feb 3.

PMID:
24410052
18.

Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.

Bogdanov A, Endrész V, Urbán S, Lantos I, Deák J, Burián K, Önder K, Ayaydin F, Balázs P, Virok DP.

Antimicrob Agents Chemother. 2014;58(1):405-13. doi: 10.1128/AAC.01400-13. Epub 2013 Nov 4.

19.

Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Mosolygó T, Korcsik J, Balogh EP, Faludi I, Virók DP, Endrész V, Burián K.

Inflamm Res. 2013 May;62(5):451-60. doi: 10.1007/s00011-013-0596-1. Epub 2013 Feb 6.

PMID:
23385305
20.

Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae.

Maier CJ, Maier RH, Virok DP, Maass M, Hintner H, Bauer JW, Onder K.

BMC Genomics. 2012 Nov 16;13:632. doi: 10.1186/1471-2164-13-632.

21.

Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.

Oláh J, Vincze O, Virók D, Simon D, Bozsó Z, Tõkési N, Horváth I, Hlavanda E, Kovács J, Magyar A, Szũcs M, Orosz F, Penke B, Ovádi J.

J Biol Chem. 2011 Sep 30;286(39):34088-100. doi: 10.1074/jbc.M111.243907. Epub 2011 Aug 8.

22.

Functional changes in transcriptomes of the prefrontal cortex and hippocampus in a mouse model of anxiety.

Virok DP, Kis Z, Szegedi V, Juhász G, Zvara A Jr, Müller G, Lévay G, Hársing LG, Rajkó R, Penke B, Janka Z, Janáky T, Puskás LG.

Pharmacol Rep. 2011;63(2):348-61.

23.

Generation of targeted Chlamydia trachomatis null mutants.

Kari L, Goheen MM, Randall LB, Taylor LD, Carlson JH, Whitmire WM, Virok D, Rajaram K, Endresz V, McClarty G, Nelson DE, Caldwell HD.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7189-93. doi: 10.1073/pnas.1102229108. Epub 2011 Apr 11.

24.

Protein array based interactome analysis of amyloid-β indicates an inhibition of protein translation.

Virok DP, Simon D, Bozsó Z, Rajkó R, Datki Z, Bálint É, Szegedi V, Janáky T, Penke B, Fülöp L.

J Proteome Res. 2011 Apr 1;10(4):1538-47. doi: 10.1021/pr1009096. Epub 2011 Feb 22.

PMID:
21244100
25.

Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.

Balogh EP, Faludi I, Virók DP, Endrész V, Burián K.

Int J Med Microbiol. 2011 Mar;301(3):252-9. doi: 10.1016/j.ijmm.2010.08.020. Epub 2010 Nov 4.

PMID:
21056004
26.

Transcriptome analysis indicates an enhanced activation of adaptive and innate immunity by chlamydia-infected murine epithelial cells treated with interferon γ.

Burian K, Endresz V, Deak J, Kormanyos Z, Pal A, Nelson D, Virok D.

J Infect Dis. 2010 Nov 1;202(9):1405-14. doi: 10.1086/656526.

27.

Chlamydophila pneumoniae and human cytomegalovirus in atherosclerotic carotid plaques--combined presence and possible interactions.

Virok D, Kis Z, Kari L, Barzo P, Sipka R, Burian K, Nelson DE, Jackel M, Kerenyi T, Bodosi M, Gönczol E, Endresz V.

Acta Microbiol Immunol Hung. 2006 Mar;53(1):35-50.

PMID:
16696549
28.

Chlamydial IFN-gamma immune evasion is linked to host infection tropism.

Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, Whitmire WM, Crane DD, Steele-Mortimer O, Kari L, McClarty G, Caldwell HD.

Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10658-63. Epub 2005 Jul 14.

29.

Chlamydial infection induces pathobiotype-specific protein tyrosine phosphorylation in epithelial cells.

Virok DP, Nelson DE, Whitmire WM, Crane DD, Goheen MM, Caldwell HD.

Infect Immun. 2005 Apr;73(4):1939-46.

30.

Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation.

Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15971-6. Epub 2003 Dec 12.

31.

Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression.

Virok D, Loboda A, Kari L, Nebozhyn M, Chang C, Nichols C, Endresz V, Gonczol E, Berencsi K, Showe MK, Showe LC.

J Infect Dis. 2003 Nov 1;188(9):1310-21. Epub 2003 Oct 13.

PMID:
14593587
32.

Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma.

Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, Wysocka M, Showe MK, Showe LC.

J Exp Med. 2003 Jun 2;197(11):1477-88.

33.

Chronic infections and atherosclerosis.

Kis Z, Burián K, Virók D, Kari G, Endrész V, Gönczöl E.

Acta Microbiol Immunol Hung. 2001;48(3-4):497-510. Review.

PMID:
11791347
34.

Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Burian K, Berencsi K, Endresz V, Gyulai Z, Valyi-Nagy T, Valyi-Nagy I, Bakay M, Geng Y, Virok D, Kari L, Hajnal-Papp R, Trinchieri G, Gonczol E.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1263-6.

35.

Chlamydia pneumoniae in atherosclerotic middle cerebral artery.

Virok D, Kis Z, Karai L, Intzedy L, Burian K, Szabo A, Ivanyi B, Gonczol E.

Stroke. 2001 Sep;32(9):1973-6.

PMID:
11546883
36.

Optimization of DNA immunization against human cytomegalovirus.

Endrész V, Burián K, Berencsi K, Gyulai Z, Kari L, Horton H, Virok D, Méric C, Plotkin SA, Gönczöl E.

Vaccine. 2001 Jul 16;19(28-29):3972-80.

PMID:
11427273
37.

Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.

Burian K, Kis Z, Virok D, Endresz V, Prohaszka Z, Duba J, Berencsi K, Boda K, Horvath L, Romics L, Fust G, Gonczol E.

Circulation. 2001 Mar 20;103(11):1503-8.

PMID:
11257076

Supplemental Content

Support Center